Looking to publish in CNS & Neurological Disorders - Drug Targets? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCNS & Neurological Disorders - Drug Targets is a journal focused on CNS and neurological disorders and drug targets. It publishes themed issues and is indexed in Scopus, SCI Expanded, and MEDLINE/PubMed. The journal lists an Impact Factor of 3 and states that open access articles are also available on ScienceDirect.
Looking to publish in CNS & Neurological Disorders - Drug Targets? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
CNS & Neurological Disorders - Drug Targets accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Mini-Reviews
Systematic Reviews
Meta-Analyses
Research Articles
Randomized Drug Clinical Trial Studies
Short Communications
Letters
Case Reports
Recent Publications
Roles of Hippocampal Alpha 6 GABAA Receptors in Clomipramine Alleviating Chronic Repeated Restraint Stress-Induced Depressive Behaviors in Rats
Linjie Yang, Shanshan Qi, Ran Qiu, Fang Wang, Hongqiao Wei, Zhenbo Feng
Linking Neurodegeneration and Age-related Macular Degeneration: Unified Pathways and Intervention Strategies
Shubhangi Mukherjee, Suman Kumar Ray, Sukhes Mukherjee
The Therapeutic Effects of Dietary Supplements on OCD: A Narrative Review
Ghazal Tavakoli, Leili Sharif Bakhtiar, Amir Ghanbari, Poorya Mohammadzadeh, Mahya Ghodousi, Kiana Kimiaei Asadi, Farzad Sheikhzadeh, Roshanak Amirian, Farhad Nikzad, Ehsan Ghoushi, Sepehr Olangian-Tehrani, Mohadeseh Poudineh
Modulating the Microbiota-gut-brain Axis: A Promising Strategy for Alzheimer’s Disease Prevention and Management
Ritu Kainth, Ajay Singh Kushwah
Understanding the OMA1-DELE1-HRI Axis and PINK1-parkin-mediated Mitophagy in Parkinson’s Disease
Shalini Singh, Anisha Sharma, Ravi Kumar Rajan, Manodeep Chakraborty, Ananya Bhattacharjee
Frequently asked questions
How long does it take to publish?
Quick Track allows online publication within 2 weeks of receipt of final approved galley proofs. Total publication time from first receipt of the manuscript to online publication is 10 weeks under Quick Track, subject to acceptance and author revision within one week. Revised papers are usually requested within 15 days, and the time frame for revision may vary from one to four weeks.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite PremiumIs a cover letter required?
A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors.
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite PremiumWhat are the publication costs?
Publication is supported by an Article Processing Charge (APC).
Reformat to CNS & Neurological Disorders - Drug Targets using Livewrite Premium